Highlighting the Prognostic Importance of Measurable Residual Disease Among Acute Myeloid Leukemia Risk Factors

OBJECTIVE: The optimal timing of measurable residual disease (MRD) evaluation in acute myeloid leukemia (AML) patients has not been well defined yet. We aimed to investigate the impact of MRD in pre- and post-allogeneic hematopoietic stem cell transplantation (AHSCT) periods on prognostic parameters...

Descripción completa

Detalles Bibliográficos
Autores principales: Narlı Özdemir, Zehra, Şahin, Uğur, Dalva, Klara, Baltacı, Mehmet Akif, Uslu, Atilla, Öztürk, Cemaleddin, Cengiz Seval, Güldane, Koçak Toprak, Selami, Kurt Yüksel, Meltem, Topçuoğlu, Pervin, Arslan, Önder, Özcan, Muhit, Beksaç, Meral, İlhan, Osman, Gürman, Günhan, Civriz Bozdağ, Sinem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171203/
https://www.ncbi.nlm.nih.gov/pubmed/33112099
http://dx.doi.org/10.4274/tjh.galenos.2020.2020.0157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171203/
https://www.ncbi.nlm.nih.gov/pubmed/33112099
http://dx.doi.org/10.4274/tjh.galenos.2020.2020.0157

Ejemplares similares